glp-1 anti-obesity What is the pipeline for future medications for obesity? GLP-1 drugs are reshaping obesity

As individuals age, NAD+ levels naturally decline, which has led to interest in supplementation with NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)

& Reiss, I

2017 Jul 17;189(28):E941

With all the traveling he was doing to different countries, he wanted to ensure that he was taking a good approach to his health in terms of nutrition

It also attracted the attention of regulators who saw a company selling prescription medications without authorization, marketing products for human consumption, and using trademarked pharmaceutical terms in their advertising

A: While not every patient experiences foot complications, the condition has become more recognized as GLP-1 drug use has increased